确定和测量评估爱尔兰药剂师处方影响的重要结果:修改后的Delphi研究
Ahmed Hassan Ali1, Barbara Clyne2, Judith Strawbridge1
1School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, Ireland.
Exploratory research in clinical and social pharmacy
|March 5, 2026
概括
这项研究确定了评估药剂师处方的关键结果,重点关注患者体验,获得护理和临床有效性. 它还评估了使用现有健康数据测量这些结果的可行性.
科学领域:
- 药房实践 在药房实践中
- 医疗保健服务研究 医疗服务研究
- 结果测量 结果测量
背景情况:
- 药剂师角色的扩大,包括处方,是全球日益增长的趋势.
- 评估扩大药剂师角色的影响对于实现目标至关重要.
研究的目的:
- 确定评估爱尔兰常见病情服务 (CCS) 中药师处方和独立处方的关键结果.
- 使用现有的健康数据确定这些结果的可测量性.
主要方法:
- 一项为期三轮的德尔菲研究,涉及30名专家,包括患者.
- 专家们使用利克特尺度和现有数据评估来评价结果的重要性和可衡量性.
- 共识被定义为≥75%将结果评为极其重要或<25%不重要.
主要成果:
- 对于CCS,七个结果达到了共识:患者体验,获得护理,指南一致性,症状改善,再咨询率,医疗保健系统成本和转诊.
- 对于其他独立的处方环境,包括死亡率,临床有效性,不良事件和患者成本,有10个结果是至关重要的.
- 可测量性各不相同",处方率" (76%的同意) 和"患者成本" (64%) 是CCS最可行的.
结论:
- 已经确定了评估药剂师处方影响的优先结果.
- 该研究使用现有的健康数据来源评估了这些结果的可衡量性.
- 调查结果包括药剂师处方评估的临床,安全,经济和以患者为中心的观点.
相关概念视频
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
56
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
56
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Pharmacokinetic–Pharmacodynamic Relationship: Problems
49
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
49
Biopharmaceutical Factors Influencing Drug Product Design: Overview
389
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
389
Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Modified-Release Drug Delivery Systems: Influencing Factors
87
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
87


